S 440
116th Congress
Senate
Commerce
Civil actions and liability
Competitiveness, trade promotion, trade deficits
Federal-Indian relations
Government liability
Intellectual property
Jurisdiction and venue
Sovereignty, recognition, national governance and status
PACED Act
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 28, 2019
Placed on Senate Legislative Calendar under General Orders. Calendar No. 129.
Jun 28, 2019
Committee on the Judiciary. Reported by Senator Graham with an amendment in the nature of a substitute. Without written report.
Jun 27, 2019
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Feb 12, 2019
Read twice and referred to the Committee on the Judiciary.
Feb 12, 2019
Introduced in Senate
Plain-English summary
Preserving Access to Cost Effective Drugs Act or the PACED Act
This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings before the International Trade Commission.
Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court. The abrogation of sovereign immunity shall not apply to states or institutions of higher education (i.e., public state universities and institutions).
What's happening now
Placed on Senate Legislative Calendar under General Orders. Calendar No. 129.
Committees of jurisdiction
1
Cosponsors
1